EAM
WGS icon

Exos Asset Management’s GeneDx Holdings WGS Stock Holding History

Exos Asset Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-383
Closed -$177K – 709
2021
Q2 		$177K Buy
383
+40
+12% +$17.2K 0.09% 276
2021
Q1 		$168K Sell
343
-20
-6% -$10.4K 0.13% 245
2020
Q4 		$132K Buy
+363
New +$126K 0.22% 130

Other funds holding WGS

Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Exos Asset Management's WGS Position: Q3 2021 in Review

Exos Asset Management sold out of GeneDx Holdings (WGS) in Q3 2021, closing a stake of 383 shares — an estimated $177K sold.

Exos Asset Management first reported a position in WGS in Q4 2020 and held it in 3 quarters. The position peaked at $177K in Q2 2021. 86 funds tracked by Wall St. Rank hold WGS as of Q3 2021.

  • Exos Asset Management reported no remaining GeneDx Holdings position as of Q3 2021 after selling out during the quarter.
  • Exos Asset Management sold 383 GeneDx Holdings shares in Q3 2021, an estimated $177K.
  • Exos Asset Management first reported a position in GeneDx Holdings in Q4 2020 and held it in 3 quarters.
  • Exos Asset Management's GeneDx Holdings position peaked at $177K in Q2 2021.
  • 86 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2021.

Based on Exos Asset Management's 13F filing for Q3 2021, filed 25 Oct 2021.